Log In
BCIQ
Print this Print this
 

MDNA11

  Manage Alerts
Collapse Summary General Information
Company Medicenna Therapeutics Inc.
DescriptionHuman anti-apoptotic Type 2 IL-4 fusion
Molecular Target
Mechanism of Action 
Therapeutic ModalityAdjuvant
Latest Stage of DevelopmentPreclinical
Standard IndicationAdjuvant
Indication DetailsVaccine adjuvant
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today